Jennifer Stevens
Equibles does not estimate personal net worth.
Get an email with a short summary when TriSalus Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get TLSI alertsAbout Jennifer Stevens
TriSalus Life Sciences, Inc. reported in an 8-K filed August 16, 2023 that Jennifer Stevens was appointed Chief Regulatory Officer, effective August 10, 2023. TriSalus Life Sciences, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at TriSalus Life Sciences, Inc. includes Mary Szela (CEO and Board Member), Karim Karti (Chairman), Mats Wahlström (Chairman and Board Member) and 7 others.
“Immediately following Closing, the New TriSalus Board appointed the following individuals as the Company's executive officers: Mary Szela to serve as Chief Executive Officer and President, Sean Murphy to serve as Chief Financial Officer, James Alecxih to serve as President, Device Technology, Steven Katz to serve as Chief Medical Officer, Bryan Cox to serve as Chief Scientific and Manufacturing Officer, Jennifer Stevens to serve as Chief Regulatory Officer, and Richard Marshak to serve as Senior Vice President, Corporate Development & Strategy.”
Affiliation history
-
TriSalus Life Sciences, Inc. (TLSI)
Proxy statement
CurrentStart not stated–present
Last confirmed March 31, 2026
Company network
Leadership on record at TriSalus Life Sciences, Inc.
- Mary Szela CEO, Board Member
- Karim Karti Chairman
- Mats Wahlström Chairman, Board Member
- David B. Patience CFO
- David Patience CFO
- James Young CFO, Head of Investor Relations
- Andrew von Eschenbach Board Member
- Anil Singhal Board Member
- Arjun Desai Board Member
- Gary Gordon Board Member